JP2026071342A5 - - Google Patents

Info

Publication number
JP2026071342A5
JP2026071342A5 JP2026017958A JP2026017958A JP2026071342A5 JP 2026071342 A5 JP2026071342 A5 JP 2026071342A5 JP 2026017958 A JP2026017958 A JP 2026017958A JP 2026017958 A JP2026017958 A JP 2026017958A JP 2026071342 A5 JP2026071342 A5 JP 2026071342A5
Authority
JP
Japan
Prior art keywords
amino acid
antigen
binding protein
items
following positions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2026017958A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026071342A (ja
Filing date
Publication date
Priority claimed from PCT/CN2021/105620 external-priority patent/WO2022007965A1/zh
Application filed filed Critical
Publication of JP2026071342A publication Critical patent/JP2026071342A/ja
Publication of JP2026071342A5 publication Critical patent/JP2026071342A5/ja
Pending legal-status Critical Current

Links

JP2026017958A 2020-07-10 2026-02-05 抗IgE改変抗体及びその適用 Pending JP2026071342A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CN202010663029 2020-07-10
CN202010663029.3 2020-07-10
CN202110750959.7 2021-07-01
CN202110750959 2021-07-01
PCT/CN2021/105620 WO2022007965A1 (zh) 2020-07-10 2021-07-09 一种抗IgE的工程化抗体及其应用
JP2023501419A JP2023541217A (ja) 2020-07-10 2021-07-09 抗IgE改変抗体及びその適用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023501419A Division JP2023541217A (ja) 2020-07-10 2021-07-09 抗IgE改変抗体及びその適用

Publications (2)

Publication Number Publication Date
JP2026071342A JP2026071342A (ja) 2026-04-28
JP2026071342A5 true JP2026071342A5 (cg-RX-API-DMAC7.html) 2026-05-11

Family

ID=79552269

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023501419A Ceased JP2023541217A (ja) 2020-07-10 2021-07-09 抗IgE改変抗体及びその適用
JP2026017958A Pending JP2026071342A (ja) 2020-07-10 2026-02-05 抗IgE改変抗体及びその適用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2023501419A Ceased JP2023541217A (ja) 2020-07-10 2021-07-09 抗IgE改変抗体及びその適用

Country Status (11)

Country Link
US (1) US20230250191A1 (cg-RX-API-DMAC7.html)
EP (1) EP4180454A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023541217A (cg-RX-API-DMAC7.html)
KR (1) KR20230042030A (cg-RX-API-DMAC7.html)
CN (1) CN116018352A (cg-RX-API-DMAC7.html)
AU (1) AU2021306786A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023000400A2 (cg-RX-API-DMAC7.html)
CA (1) CA3185192A1 (cg-RX-API-DMAC7.html)
IL (1) IL299747A (cg-RX-API-DMAC7.html)
TW (1) TWI896700B (cg-RX-API-DMAC7.html)
WO (1) WO2022007965A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL318098A (en) 2022-07-01 2025-02-01 Alk Abell? As IGE-FCER pushers
CN116143932B (zh) * 2022-12-07 2025-02-11 南开大学 一种针对IgE的抗体或其抗原结合片段以及Fc变体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1260521B1 (en) 1991-08-14 2007-11-21 Genentech Inc. Immunoglobulin variants for specific Fc epsilon receptors
CA2226575C (en) 1995-07-27 2011-10-18 Genentech, Inc. Stabile isotonic lyophilized protein formulation
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
ZA966075B (en) 1995-07-27 1998-01-19 Genentech Inc Protein formulation.
US5994511A (en) * 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
US20030190598A1 (en) 2000-05-26 2003-10-09 Jasmid Tanha Single-domain antigen-binding antibody fragments derived from llama antibodies
NZ601815A (en) * 2008-03-31 2014-10-31 Genentech Inc Compositions and methods for treating and diagnosing asthma
US20180273626A1 (en) * 2015-09-11 2018-09-27 The Board Of Trustees Of The Leland Stanford Junio University Omalizumab resistant ige variants and their use in anti-ige therapy
GB201610198D0 (en) * 2016-06-10 2016-07-27 Ucb Biopharma Sprl Anti-ige antibodies
EP4342541A3 (en) * 2017-04-07 2024-07-03 Kookmin University Industry Academy Cooperation Foundation Antibody fc variants for increased blood half-life
KR20220098056A (ko) * 2018-02-09 2022-07-08 제넨테크, 인크. 비만 세포 매개 염증성 질환에 대한 치료 및 진단 방법
EP3788078A4 (en) * 2018-05-04 2022-03-02 Allakos Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF CHRONIC URTICARIA

Similar Documents

Publication Publication Date Title
US10442857B2 (en) Anti-IL-17 antibodies
CN106102837B (zh) 双特异性hiv-1-中和抗体
ES2567198T3 (es) Antagonistas de la IL-1 beta humana
RU2004117915A (ru) Модифицированное анти-tnf альфа антитело
CN101679507A (zh) 结晶抗人类il-12抗体
AU2018398341B2 (en) Monoclonal antibodies and methods for using same
TW201620935A (zh) 基於vl和vнн可變區衍生物的高親和力抗聚集抗體
TW200835699A (en) Crystalline anti-hTNFalpha antibodies
TWI859623B (zh) Il10單體融合蛋白及其應用
CN106039306A (zh) 使用针对TNFα的单结构域抗体治疗免疫病症的方法
TW200812616A (en) Binding polypeptides with optimized scaffolds
TR201808057T4 (tr) Il-17 antagonistik antikorları.
TWI797400B (zh) 抗IL17a抗體的水性藥物組合物及其用途
CN104327187A (zh) 一种重组人GLP-1-Fc融合蛋白
BRPI1013341B1 (pt) Variantes de domínio variável único de imunoglobulina anti-albumina de soro, ligante multiespecífico e composição que compreendem as ditas variantes, bem como ácidos nucleicos e vetor
JP2025512865A5 (cg-RX-API-DMAC7.html)
WO2021052307A1 (zh) 一种抗b7-h3抗体及其应用
JP2003502024A (ja) タンパク質骨格および単量体ポリペプチドを多量体化するためのその使用
US20250388684A1 (en) Anti-ccr8 antibody and use thereofr
JP2023541217A5 (cg-RX-API-DMAC7.html)
RU2656160C2 (ru) Антитело или его антигенсвязывающий фрагмент, способный связываться с рецептором интерлейкина-6 человека
CN114805578A (zh) 一种白细胞免疫球蛋白样受体亚家族b成员2的羊驼纳米抗体、制备方法及其应用
CN116018352A (zh) 一种抗IgE的工程化抗体及其应用
TW201444576A (zh) 具有降低黏度的調配物
CN104744592A (zh) 抗HER2-抗CD3 scFv双特异四价抗体